144 related articles for article (PubMed ID: 38448888)
1. Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.
Rabe M; Dietrich O; Forbrig R; Niyazi M; Belka C; Corradini S; Landry G; Kurz C
Radiat Oncol; 2024 Mar; 19(1):31. PubMed ID: 38448888
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD
Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282
[TBL] [Abstract][Full Text] [Related]
3. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
Habrich J; Boeke S; Nachbar M; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
Radiother Oncol; 2022 Sep; 174():141-148. PubMed ID: 35902042
[TBL] [Abstract][Full Text] [Related]
4. Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients.
Lawrence LSP; Chan RW; Chen H; Keller B; Stewart J; Ruschin M; Chugh B; Campbell M; Theriault A; Stanisz GJ; MacKenzie S; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Czarnota GJ; Sahgal A; Lau AZ
Radiother Oncol; 2021 Nov; 164():155-162. PubMed ID: 34592363
[TBL] [Abstract][Full Text] [Related]
5. Validation of echo planar imaging based diffusion-weighted magnetic resonance imaging on a 0.35 T MR-Linac.
Wallimann P; Piccirelli M; Nowakowska S; Armstrong T; Mayinger M; Boss A; Bink A; Guckenberger M; Tanadini-Lang S; Andratschke N; Pouymayou B
Phys Imaging Radiat Oncol; 2024 Apr; 30():100579. PubMed ID: 38707628
[TBL] [Abstract][Full Text] [Related]
6. Distortion-free diffusion MRI using an MRI-guided Tri-Cobalt 60 radiotherapy system: Sequence verification and preliminary clinical experience.
Gao Y; Han F; Zhou Z; Cao M; Kaprealian T; Kamrava M; Wang C; Neylon J; Low DA; Yang Y; Hu P
Med Phys; 2017 Oct; 44(10):5357-5366. PubMed ID: 28692129
[TBL] [Abstract][Full Text] [Related]
7. Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator.
Wong OL; Yuan J; Poon DMC; Chiu ST; Yang B; Chiu G; Yu SK; Cheung KY
Magn Reson Imaging; 2024 Mar; 111():47-56. PubMed ID: 38513789
[TBL] [Abstract][Full Text] [Related]
8. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diffusion-weighted MRI and geometric distortion on a 0.35T MR-LINAC at multiple gantry angles.
Lewis B; Guta A; Mackey S; Gach HM; Mutic S; Green O; Kim T
J Appl Clin Med Phys; 2021 Feb; 22(2):118-125. PubMed ID: 33450146
[TBL] [Abstract][Full Text] [Related]
10. Rapid multicontrast brain imaging on a 0.35T MR-linac.
Nejad-Davarani SP; Zakariaei N; Chen Y; Haacke EM; Hurst NJ; Salim Siddiqui M; Schultz LR; Snyder JM; Walbert T; Glide-Hurst CK
Med Phys; 2020 Sep; 47(9):4064-4076. PubMed ID: 32434276
[TBL] [Abstract][Full Text] [Related]
11. Validating the accuracy of multispectral metal artifact suppressed diffusion-weighted imaging.
Neri JP; Koff MF; Koch KM; Tan ET
Med Phys; 2022 Oct; 49(10):6538-6546. PubMed ID: 35953390
[TBL] [Abstract][Full Text] [Related]
12. Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapy.
Lutsik N; Nejad-Davarani SP; Valderrama A; Herr J; Maziero D; Cullison K; Azzam GA; Kubicek GJ; Meshman J; de la Fuente MI; Armstrong T; Mellon EA
Med Phys; 2024 Apr; ():. PubMed ID: 38588475
[TBL] [Abstract][Full Text] [Related]
13. ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium.
Kooreman ES; van Houdt PJ; Keesman R; Pos FJ; van Pelt VWJ; Nowee ME; Wetscherek A; Tijssen RHN; Philippens MEP; Thorwarth D; Wang J; Shukla-Dave A; Hall WA; Paulson ES; van der Heide UA
Radiother Oncol; 2020 Dec; 153():106-113. PubMed ID: 33017604
[TBL] [Abstract][Full Text] [Related]
14. A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging.
Matsuya R; Kuroda M; Matsumoto Y; Kato H; Matsuzaki H; Asaumi J; Murakami J; Katashima K; Ashida M; Sasaki T; Sei T; Himei K; Katsui K; Katayama N; Takemoto M; Kanazawa S; Mimura S; Oono S; Kitayama T; Tahara S; Inamura K
Int J Oncol; 2009 Oct; 35(4):893-900. PubMed ID: 19724927
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.
Tyagi N; Cloutier M; Zakian K; Deasy JO; Hunt M; Rimner A
J Appl Clin Med Phys; 2019 Jan; 20(1):284-292. PubMed ID: 30421496
[TBL] [Abstract][Full Text] [Related]
16. Improving apparent diffusion coefficient accuracy on a compact 3T MRI scanner using gradient nonlinearity correction.
Tao AT; Shu Y; Tan ET; Trzasko JD; Tao S; Reid RD; Weavers PT; Huston J; Bernstein MA
J Magn Reson Imaging; 2018 Dec; 48(6):1498-1507. PubMed ID: 30255963
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
[TBL] [Abstract][Full Text] [Related]
18. Comparison and evaluation of distortion correction techniques on an MR-guided radiotherapy system.
Gao Y; Yoon S; Savjani R; Pham J; Kalbasi A; Raldow A; Low DA; Hu P; Yang Y
Med Phys; 2021 Feb; 48(2):691-702. PubMed ID: 33280128
[TBL] [Abstract][Full Text] [Related]
19. Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.
Fernando N; Tadic T; Li W; Patel T; Padayachee J; Santiago AT; Dang J; Chung P; Gutierrez E; Coolens C; Taylor E; Winter JD
Phys Imaging Radiat Oncol; 2024 Apr; 30():100570. PubMed ID: 38544680
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation.
Lawrence LSP; Chan RW; Chen H; Stewart J; Ruschin M; Theriault A; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Soliman H; Jane Lim-Fat M; Das S; Stanisz GJ; Sahgal A; Lau AZ
Radiother Oncol; 2023 Nov; 188():109873. PubMed ID: 37640160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
